Uterine Cancer CyberKnife® VSI™ Robotic Radiosurgery System
Learn More About Uterine Cancer CyberKnife®: Chat with Us | Email Us
The CyberKnife® VSI™ Robotic Radiosurgery System enables our radiation oncologists to destroy difficult-to-reach tumors in the uterus with high doses of precisely directed radiation, rather than with open surgery.
CyberKnife provides a pain-free, minimally invasive option for uterine cancer patients who are unable to undergo surgery, or who do not want surgery. For uterine cancer patients, CyberKnife is used to treat metastatic or locally recurrent disease.
How Does CyberKnife Treat Uterine Cancer?
Prior to the procedure, a high-resolution CT scan determines the size, shape and location of the tumor within the uterus. The image data is then digitally transferred to the CyberKnife System’s workstation, where we precisely plan treatment to match the desired radiation dose to the exact tumor location.
Once treatment planning is complete, the patient is comfortably positioned on a cushioned table and the system’s computer-controlled robot slowly moves around the table, targeting radiation to the tumor from various angles while sparing surrounding healthy tissue.
The system’s sophisticated software allows us to track the uterine tumor and continually adjust the radiation treatment to account for patient or tumor movement.
CyberKnife treatment for uterine cancer is typically completed in four to five sessions, depending on the location of the tumor and other factors.
Advantage of Cyberknife for Uterine Cancer
CyberKnife provides a pain-free, non-surgical option for uterine cancer patients who have inoperable or surgically complex tumors, or who may be looking for an alternative to surgery.
The following are the potential benefits of treatment with the CyberKnife VSI System:
- No incision
- No pain
- No anesthesia or hospitalization
- No invasive head or body frame
- Greater comfort (patient can breathe normally during treatment)
- Little or no recovery time
- Immediate return to normal activities
Next Topic: Chemotherapy for Uterine Cancer